Agenda at a Glance


In 2018, we will have over 150 speakers leading the discussion on achieving patient access to innovative medicines.

We are currently finalizing the 2018 agenda! Topics of discussion will include data generation, novel therapeutics, payer partnerships and strategies for growth and development.

If you are interested in speaking at our event, contact Ryan Anderson now at +1 646 619 1775 or


Top speakers from 2017 included:  ‚Äč

  • Jonathan Jarrow , Senior Medical Advisor to the Center Director of CDER,  FDA
  • Boxiong Tang ,  Senior Director,  Teva Pharmaceuticals
  • Douglas Nanton,  Market Access and Government Affairs -Western Canada and Ottawa,  Valeant Pharmaceuticals Canada
  • Shanthy Krishnaraja,  Head of Global Health Economics and Reimbursement Strategy,  CSL Behring Sachin
  • Kamal-Bahl,  Vice President & Head, Global Health & Value Innovation Center,  Pfizer
  • David Davidovic,  Former Vice President & Global Head, Commercial Services,  Roche
  • Genentech Michael Reilly,  Executive Director,  Alliance for Safe Biologic Medicines
  • Jim McKay,  Director, Clinical Development and Medical Affairs,  Sandoz
  • Dr. S.D.Ravetkar,  Executive Director,  Serum Institute of India PVD LTD
  • Peter Dehnel,  Medical Director,  Blue Cross and Blue Shield of Minnesota
  • Anna Bucsics,  External Lecturer, MoCA board member,  University of Vienna
  • James Barbeau,  Director of Clinical Pathology,  Lifespan/Brown University
  • Nadia Turchetta,  Executive Director, Biopharmaceuticals,  Sandoz
  • Marla Curran,  Senior Director and Head, Global Epidemiology and Evidence-based Statistics,  Merck


Agenda at a glance


Get involved!

Contact Michael Shackhil at +1 646 619 1809  or